Eton Pharmaceuticals Inc (ETON)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -128.528 | -178.257 | -80.707 | -128.921 | -7.27 | -34.369 | -3.298 |
Return on Equity (%) | 251.353 | -383.231 | -99.422 | -213.406 | -11.744 | -58.753 | -6.556 |
Return on Invested Capital (%) | 207.066 | -106.581 | -89.327 | -144.119 | -5.705 | -32.153 | -3.438 |
Operating Margin (%) | N/A | N/A | -1910.323 | -69515.385 | -4.347 | -38.869 | -2.177 |
Net Profit Margin (%) | N/A | N/A | -1910.323 | -71717.949 | -8.955 | -42.45 | -2.958 |
Book Value Per Share | -1.146 | 1.494 | 0.55 | 0.621 | 0.569 | 0.328 | 0.419 |
Earnings Per Share | -1.44 | -2.114 | -1.025 | -1.15 | -0.079 | -0.356 | -0.036 |
Cash Per Share | 2.193 | 1.518 | 0.675 | 0.876 | 0.585 | 0.643 | 0.834 |
Working Capital Per Share | 2.083 | 1.447 | 0.73 | 0.86 | 0.773 | 0.534 | 0.413 |
Operating Profit Per Share | N/A | N/A | 0.028 | -0.01 | 0.78 | 0.565 | 0.856 |
EBIT Per Share | -1.193 | -0.724 | -1.025 | -1.15 | -0.079 | -0.356 | -0.027 |
EBITDA Per Share | -1.193 | -0.724 | -1.025 | -1.15 | -0.079 | -0.356 | -0.027 |
Free Cash Flow Per Share | -1.42 | -2.104 | -0.947 | -1.169 | 0.038 | -0.312 | -0.041 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 6M | 17.61M | 17.88M | 24.31M | 24.63M | 25.35M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 25.3M | 25.35M | N/A | 25.56M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -47.775 | N/A | N/A | N/A | -10.043 | N/A |
Net Profit Margin (%) | N/A | N/A | -50.151 | N/A | N/A | N/A | -10.181 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 321.66M |
Price to Earnings Ratio | -351.93 |
Price to Sales Ratio | 10.4 |
Price to Cash Ratio | 15.39 |
Price to Book Ratio | 21.27 |
Dividend Yield | - |
Shares Outstanding | 25.84M |
Average Volume (1 week) | 356.08k |
Average Volume (1 Month) | 272.25k |
52 Week Change | 239.73% |
52 Week High | 12.74 |
52 Week Low | 3.03 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.